Allianz Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $946K | Sell |
12,601
-4,115
| -25% | -$325K | ﹤0.01% | 1723 |
|
|
2025
Q4 | $1.32M | Buy |
16,716
+5,216
| +45% | +$393K | ﹤0.01% | 1645 |
|
|
2025
Q3 | $752K | Buy |
+11,500
| New | +$561K | ﹤0.01% | 1768 |
|
|
2023
Q3 | – | Sell |
-23,100
| Closed | -$948K | – | 2223 |
|
|
2023
Q2 | $948K | Sell |
23,100
-85,148
| -79% | -$3.27M | ﹤0.01% | 1546 |
|
|
2023
Q1 | $3.87M | Buy |
108,248
+5,761
| +6% | +$216K | 0.01% | 1071 |
|
|
2022
Q4 | $3.87M | Buy |
102,487
+73,607
| +255% | +$3.1M | 0.01% | 1019 |
|
|
2022
Q3 | $1.28M | Buy |
28,880
+6,383
| +28% | +$269K | ﹤0.01% | 1361 |
|
|
2022
Q2 | $833K | Sell |
22,497
-59,333
| -73% | -$2.24M | ﹤0.01% | 1740 |
|
|
2022
Q1 | $3.03M | Hold |
81,830
| – | – | ﹤0.01% | 1436 |
|
|
2021
Q4 | $2.49M | Buy |
81,830
+62,120
| +315% | +$1.96M | ﹤0.01% | 1524 |
|
|
2021
Q3 | $661K | Hold |
19,710
| – | – | ﹤0.01% | 2107 |
|
|
2021
Q2 | $786K | Sell |
19,710
-15,134
| -43% | -$593K | ﹤0.01% | 1840 |
|
|
2021
Q1 | $1.57M | Hold |
34,844
| – | – | ﹤0.01% | 1493 |
|
|
2020
Q4 | $1.97M | Buy |
+34,844
| New | +$1.74M | ﹤0.01% | 1320 |
|
|
2020
Q3 | – | Sell |
-4,192
| Closed | -$247K | – | 2120 |
|
|
2020
Q2 | $247K | Sell |
4,192
-800
| -16% | -$44.5K | ﹤0.01% | 2240 |
|
|
2020
Q1 | $236K | Sell |
4,992
-1,100
| -18% | -$61.3K | ﹤0.01% | 2293 |
|
|
2019
Q4 | $368K | Sell |
6,092
-315
| -5% | -$18.8K | ﹤0.01% | 2512 |
|
|
2019
Q3 | $384K | Buy |
6,407
+544
| +9% | +$35.5K | ﹤0.01% | 2452 |
|
|
2019
Q2 | $377K | Sell |
5,863
-4,870
| -45% | -$344K | ﹤0.01% | 2436 |
|
|
2019
Q1 | $871K | Sell |
10,733
-44,510
| -81% | -$2.87M | ﹤0.01% | 2143 |
|
|
2018
Q4 | $2.94M | Sell |
55,243
-4,137
| -7% | -$211K | ﹤0.01% | 1615 |
|
|
2018
Q3 | $3.06M | Hold |
59,380
| – | – | ﹤0.01% | 1780 |
|
|
2018
Q2 | $2.47M | Hold |
59,380
| – | – | ﹤0.01% | 1848 |
|
|
2018
Q1 | $2.62M | Sell |
59,380
-9,500
| -14% | -$483K | ﹤0.01% | 1805 |
|
|
2017
Q4 | $3.46M | Buy |
+68,880
| New | +$3.78M | ﹤0.01% | 1789 |
|
|
2015
Q2 | – | Sell |
-4,805
| Closed | -$306K | – | 2433 |
|
|
2015
Q1 | $306K | Buy |
+4,805
| New | +$326K | ﹤0.01% | 2112 |
|
|
2014
Q3 | – | Sell |
-110,000
| Closed | -$3.79M | – | 2345 |
|
|
2014
Q2 | $3.79M | Sell |
110,000
-249,670
| -69% | -$7.86M | ﹤0.01% | 1017 |
|
|
2014
Q1 | $15.5M | Sell |
359,670
-230,555
| -39% | -$11.2M | 0.02% | 623 |
|
|
2013
Q4 | $23.5M | Buy |
590,225
+221,740
| +60% | +$7.9M | 0.03% | 510 |
|
|
2013
Q3 | $13.8M | Sell |
368,485
-729,242
| -66% | -$21.8M | 0.02% | 587 |
|
|
2013
Q2 | $29.5M | Buy |
+1,097,727
| New | +$23.3M | 0.04% | 420 |
|
Other funds holding IONS
VPM
VCM
Allianz Asset Management's IONS Position: Q1 2026 in Review
Allianz Asset Management reduced its Ionis Pharmaceuticals (IONS) stake by 25% in Q1 2026, selling an estimated $325K and leaving 12,601 shares worth $946K. The position accounts for ﹤0.01% of the portfolio, ranked #1723.
Allianz Asset Management first reported a position in IONS in Q2 2013 and has held it in 31 quarters since. The position peaked at $29.5M in Q2 2013. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Allianz Asset Management held 12,601 shares of Ionis Pharmaceuticals worth $946K as of Q1 2026.
- Allianz Asset Management sold 4,115 Ionis Pharmaceuticals shares in Q1 2026, an estimated $325K.
- Ionis Pharmaceuticals made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1723 holding.
- Allianz Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 31 quarters since.
- Allianz Asset Management's Ionis Pharmaceuticals position peaked at $29.5M in Q2 2013.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.